Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 06:10 am Sale | 2024-09-30 | 13G | Avadel Pharmaceuticals plc AVDL | RTW INVESTMENTS LP | 0 0.000% | -9,196,186 (Position Closed) | Filing History |
| 2024-11-14 06:07 am Sale | 2024-09-30 | 13G | Adicet Bio, Inc. ACET | RTW INVESTMENTS LP | 0 0.000% | -4,134,631 (Position Closed) | Filing History |
| 2024-10-24 5:19 pm Sale | 2024-10-22 | 13D | Allurion Technologies Inc. ALUR | RTW INVESTMENTS LP | 146,664 5.700% | -30,000 (-16.98%) | Filing History |
| 2024-08-23 5:46 pm Purchase | 2024-08-22 | 13D | Avidity Biosciences, Inc. RNA | RTW INVESTMENTS LP | 12,079,734 9.990% | 2,419,925 (+25.05%) | Filing History |
| 2024-08-07 5:19 pm Purchase | 2024-08-05 | 13D | Orchestra BioMed Holdings, Inc. OBIO | RTW INVESTMENTS LP | 7,704,030 21.500% | 2,083,385 (+37.07%) | Filing History |
| 2024-07-02 5:51 pm Purchase | 2024-06-28 | 13D | Allurion Technologies Inc. ALUR | RTW INVESTMENTS LP | 176,663 7.000% | 19,187 (+12.18%) | Filing History |
| 2024-04-17 6:57 pm Purchase | 2024-04-16 | 13D | Allurion Technologies Inc. ALUR | RTW INVESTMENTS LP | 157,476 8.100% | 157,476 (New Position) | Filing History |
| 2024-03-01 4:15 pm Purchase | 2024-02-28 | 13D | Avidity Biosciences, Inc. RNA | RTW INVESTMENTS LP | 9,659,809 9.990% | 2,958,320 (+44.14%) | Filing History |
| 2024-02-14 07:57 am Purchase | 2023-12-31 | 13G | Immunocore Holdings plc IMCR | RTW INVESTMENTS LP | 6,096,387 12.300% | 537,065 (+9.66%) | Filing History |
| 2024-02-14 07:55 am Purchase | 2023-12-31 | 13G | Immunic, Inc. IMUX | RTW INVESTMENTS LP | 4,335,255 9.600% | 473,965 (+12.27%) | Filing History |
| 2024-02-14 07:53 am Purchase | 2023-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | RTW INVESTMENTS LP | 5,469,956 8.800% | 476,677 (+9.55%) | Filing History |
| 2024-02-14 07:52 am Sale | 2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | RTW INVESTMENTS LP | 0 0.000% | -4,356,920 (Position Closed) | Filing History |
| 2024-02-14 07:49 am Sale | 2023-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | RTW INVESTMENTS LP | 0 0.000% | -2,067,824 (Position Closed) | Filing History |
| 2024-02-14 07:47 am Purchase | 2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | RTW INVESTMENTS LP | 5,315,514 9.200% | 1,723,528 (+47.98%) | Filing History |
| 2024-02-14 07:46 am Purchase | 2023-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | RTW INVESTMENTS LP | 6,887,086 8.400% | 6,887,086 (New Position) | Filing History |
| 2024-02-14 07:44 am Purchase | 2023-12-31 | 13G | Stoke Therapeutics, Inc. STOK | RTW INVESTMENTS LP | 4,131,045 9.300% | 260,064 (+6.72%) | Filing History |
| 2024-02-14 07:42 am Purchase | 2023-12-31 | 13G | Vericel Corporation VCEL | RTW INVESTMENTS LP | 3,212,794 6.700% | 112,890 (+3.64%) | Filing History |
| 2024-02-14 07:40 am Purchase | 2023-12-31 | 13G | Establishment Labs Holdings Inc. ESTA | RTW INVESTMENTS LP | 2,494,138 9.700% | 120,000 (+5.05%) | Filing History |
| 2024-02-14 07:38 am Purchase | 2023-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | RTW INVESTMENTS LP | 3,463,201 6.300% | 378,986 (+12.29%) | Filing History |
| 2024-02-14 07:35 am Sale | 2023-12-31 | 13G | C4 Therapeutics, Inc. CCCC | RTW INVESTMENTS LP | 0 0.000% | -2,819,472 (Position Closed) | Filing History |